搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Vibrio cholerae serotype O1 UPF0250 protein VC_0945 (VC_0945) CSB-YP888623VEX
CSB-EP888623VEX
CSB-BP888623VEX
CSB-MP888623VEX
CSB-EP888623VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Protein syd (syd) CSB-YP888624VEX
CSB-EP888624VEX
CSB-BP888624VEX
CSB-MP888624VEX
CSB-EP888624VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Proline--tRNA ligase (proS), partial CSB-YP888625VEX
CSB-EP888625VEX
CSB-BP888625VEX
CSB-MP888625VEX
CSB-EP888625VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 GTPase Der (der) CSB-YP888626VEX
CSB-EP888626VEX
CSB-BP888626VEX
CSB-MP888626VEX
CSB-EP888626VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Peptidase B (pepB) CSB-YP888627VEX
CSB-EP888627VEX
CSB-BP888627VEX
CSB-MP888627VEX
CSB-EP888627VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Copper homeostasis protein CutC (cutC) CSB-YP888628VEX
CSB-EP888628VEX
CSB-BP888628VEX
CSB-MP888628VEX
CSB-EP888628VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UPF0169 lipoprotein VC_0708 (VC_0708) CSB-YP888629VEX
CSB-EP888629VEX
CSB-BP888629VEX
CSB-MP888629VEX
CSB-EP888629VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 N-acetylmuramic acid 6-phosphate etherase 2 (murQ2) CSB-YP888630VEX
CSB-EP888630VEX
CSB-BP888630VEX
CSB-MP888630VEX
CSB-EP888630VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP888631VEX
CSB-EP888631VEX
CSB-BP888631VEX
CSB-MP888631VEX
CSB-EP888631VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Iron-sulfur cluster insertion protein ErpA (erpA) CSB-YP888632VEX
CSB-EP888632VEX
CSB-BP888632VEX
CSB-MP888632VEX
CSB-EP888632VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Penicillin-binding protein activator LpoA (lpoA), partial CSB-YP888633VEX
CSB-EP888633VEX
CSB-BP888633VEX
CSB-MP888633VEX
CSB-EP888633VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 S-ribosylhomocysteine lyase (luxS) CSB-YP888634VEX
CSB-EP888634VEX
CSB-BP888634VEX
CSB-MP888634VEX
CSB-EP888634VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Cell division protein FtsB (ftsB), partial CSB-YP888635VEX
CSB-EP888635VEX
CSB-BP888635VEX
CSB-MP888635VEX
CSB-EP888635VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Probable Fe (2+)-trafficking protein (VC_0451) CSB-YP888636VEX
CSB-EP888636VEX
CSB-BP888636VEX
CSB-MP888636VEX
CSB-EP888636VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Arginine repressor (argR) CSB-YP888637VEX
CSB-EP888637VEX
CSB-BP888637VEX
CSB-MP888637VEX
CSB-EP888637VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 UvrABC system protein A (uvrA), partial CSB-YP888638VEX
CSB-EP888638VEX
CSB-BP888638VEX
CSB-MP888638VEX
CSB-EP888638VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Sulfite reductase [NADPH] flavoprotein alpha-component (cysJ), partial CSB-YP888639VEX
CSB-EP888639VEX
CSB-BP888639VEX
CSB-MP888639VEX
CSB-EP888639VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Elongation factor Tu-B (tufB) CSB-YP888640VEX
CSB-EP888640VEX
CSB-BP888640VEX
CSB-MP888640VEX
CSB-EP888640VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Sulfurtransferase TusD homolog (tusD) CSB-YP888641VEX
CSB-EP888641VEX
CSB-BP888641VEX
CSB-MP888641VEX
CSB-EP888641VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP888642VEX
CSB-EP888642VEX
CSB-BP888642VEX
CSB-MP888642VEX
CSB-EP888642VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>